Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Ahead of Print Article(s)

Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases

Volume:18
Oliesia Gonzales Quinones and Maria Bernadete Riemma Pierre*

Role of MicroRNAs in Treatment Response in Prostate Cancer

Volume:18
Anshuli Razdan, Paul de Souza* and Tara Laurie Roberts

Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression

Volume:18
Afraa Mamoori, Vinod Gopalan and Alfred K-Y Lam*

Noxa: Role in Cancer Pathogenesis and Treatment

Volume:18
Rami Z. Morsi, Rouba Hage-Sleiman, Hadile Kobeissy and Ghassan Dbaibo*

Parp Inhibitors for the Treatment of Ovarian Cancer

Volume:18
Laura Cortesi, Angela Toss* and Iole Cucinotto

Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis

Volume:18
Francesco Passiglia, Sergio Rizzo, Christian Rolfo, Antonio Galvano, Enrico Bronte, Lorena Incorvaia, Angela Listi, Nadia Barraco, Marta Castiglia, Valentina Calo, Viviana Bazan and Antonio Russo*

Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development

Volume:18
Mubeena PM Mariyath, Mehdi Hayat Shahi*, Shirin Farheen, Mohd Tayyab, Nabeela Khanam and Asif Ali

SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer

Volume:18
Dongbo Yuan*, Wei Wang*, Jiaming Su*, Yongqiang Zhang, Boshi Luan, Haofu Rao, Tianfei Cheng, Wei Zhang, Shiwei Xiao, Mingsheng Zhang, Fu-Neng Jiang, Zhaolin Sun, Zhenyu Jia, Wei-De Zhong and Jianguo Zhu

Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update

Volume:18
Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojgan Bandehpour

Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - Clinical Implications

Volume:18
Katarina Kalavska, Vincenza Conteduca, Ugo De Giorgi and Michal Mego*

Anticancer Properties of Essential Oils: An Overview

Volume:18
Milene Aparecida Andrade, Mariana Aparecida Braga, Pedro Henrique Souza Cesar, Marcus Vinicius Cardoso Trento, Mariana Araujo Esposito and Lucilene Fernandes Silva*

Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis

Volume:18
Ana Sahores, Maria May, Gonzalo Sequeira, Cynthia Fuentes, Britta Jacobsen, Claudia Lanari and Caroline Ana Lamb*

Towards Prevention of Ovarian Cancer

Volume:18
Aus Tariq Ali*

Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy

Volume:18
Jie Wu, Dingxin Di, Chen Zhao, Yingyi Liu, Hongxia Chen, Yan Gong, Xianda Zhao and Honglei Chen*

Tunneling Nanotubes: A Versatile Target for Cancer Therapy

Volume:18
Pragyaparamita Sahoo, Soumya Ranjan Jena and Luna Samanta*

AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer

Volume:17
Samanta Salvi*, Vincenza Conteduca, Cristian Lolli, Sara Testoni, Valentina Casadio, Andrea Zaccheroni, Lorena Rossi, Salvatore Luca Burgio, Cecilia Menna, Giuseppe Schepisi and Ugo De Giorgi

A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent

Volume:17
Rand R. Hafidh*, Saba Z. Hussein, Mohammed Q. MalAllah, Ahmed S. Abdulamir and Fatimah Abu Bakar

Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment

Volume:17
Natalia Lisiak*, Ewa Toton and Maria Rybczynska

Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling

Volume:17
Xinhua Xie, Xiaojia Huang, Hailin Tang, Feng Ye, Lu Yang, Xiaofang Guo, Zhi Tian, Cheng Peng* and Xiaoming Xie*

Degradation of Androgen Receptor through Small Molecules for Prostate Cancer

Volume:17
Raoling Ge, Xi Xu, Pengfei Xu, Lei Li, Zhiyu Li* and Jinlei Bian

Oxidative Stress and Cancer: The Role of Nrf2

Volume:17
Sajadimajd Soraya and Khazaei Mozafar*

Development of Drug Targeting and Delivery in Cervical Cancer

Volume:17
Urvashi Aggarwal, Amit Kumar Goyal and Goutam Rath*

Ponatinib: A Review of Efficacy and Safety

Volume:17
Fulvio Massaro, Matteo Molica and Massimo Breccia*

Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required

Volume:17
Sepideh Mansouri, Leila Farahmand, Azin Teymourzadeh and Keivan Majidzadeh-A*

Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice

Volume:17
Ashish Saxena, Ravinder Tammali, Kota V Ramana and Satish K. Srivastava*

Evaluation of Anti-cancer Activity of Stilbene and Methoxydibenzo[b,f] oxepin Derivatives

Volume:17
Damian Garbicz , Damian Mielecki , Michał Wrzesiński , Tomasz Pilżys, Michał Marcinkowski , Jan Piwowarski , Janusz Dębski, Ewelina Palak, Przemysław Szczeciński, Hanna Krawczyk and Elżbieta Grzesiuk*

An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein

Volume:17
Xiaoqian Yang, Xiaoduan Li, Zhenfeng Duan and Xipeng Wang*

The Structural Bioinformatics Analysis of Biophenolic Lignan-Estrogen Receptor Interaction

Volume:17
Farzaneh Mohamadyar-Toupkanlou*, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri Renani and Masoud Soleimani

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

Volume:17
Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra

Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

Volume:17
Dhaval Sanchala, Lokesh K Bhatt* and Kedar S Prabhavalkar

Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention

Volume:17
Sadegh Babashah*, Babak Bakhshinejad, Maryam Tahmasebi Birgani , Katayoon Pakravan and William C Cho*

Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents

Volume:17
Leila Farahmand, Parnaz Merikhian, Neda Jalili, Behrad Darvishi and Keivan Majidza*

Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells

Volume:17
Tiantian Zhang, Dennis H Kordish, Yogesh R Suryawanshi, Rob R Eversole, Steven Kohler, Charles D Mackenzie and Karim Essani*

Fertility Drugs and Ovarian Cancer

Volume:17
Aus Tariq Ali*

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

Volume:17
Marzieh Ghanemi, Aminollah Pourshohod, Mohammad Ali Ghaffari , Alireza kheirollah, Mansour Amin, Majid Zeinali* and Mostafa Jamalan*

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Volume:17
Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, Alessandro Casellato, Paolo Macaccaro, Laura Quotti Tubi, Andrea Visentin, Livio Trentin, Gianpietro Semenzato and Francesco Piazza*